Abstract
The development of effective drug delivery systems is very challenging due to poor solubility, low membrane permeability, instability, and short biological half-life of active substances. Conventional drug delivery systems lack the features of extended drug release and targeted drug delivery. These issues can be solved by cyclodextrins and derivatives. Benefits include higher bioavailability, targeted drug delivery, non-toxicity, inclusion complex ability, and higher aqueous solubility. Cyclodextrin-conjugated nanoparticles combine the advantages of cyclodextrins and nanoparticles: enhanced water solubility and drug loading, targeted drug delivery with minimum toxicity to normal cells, greater surface area, improved drug loading and higher stability than other nanocarriers such as microparticles and liposomes. Here, I review cyclodextrin-containing nanoparticles and their applications in advanced drug delivery such as anticancer drugs, gene delivery, protein, and peptide drug delivery. Furthermore, this review also describes cyclodextrins applications using polymeric, gold, silver, magnetic, and lipid-based nanoparticles. Additionally, I present potential pharmaceutical applications of amphiphilic cyclodextrin-based nanoparticles in anticancer, antimicrobial, gene delivery, and miscellaneous administration routes of cyclodextrin-based nanoparticles such as nasal and transdermal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- MCF-7:
-
Michigan cancer foundation-7
- MDR1:
-
Multidrug resistance protein 1
- mRNA:
-
Messenger ribonucleic acid
- siRNA:
-
Small interfering ribonucleic acid
References
Agüeros M, Ruiz-Gatón L, Vauthier C, Bouchemal K, Espuelas S, Ponchel G, Irache JM (2009) Combined hydroxypropyl-β-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel. Eur J Pharm Sci 38:405–413. https://doi.org/10.1016/j.ejps.2009.09.010
Agüeros M, Espuelas S, Esparza I, Calleja P, Peñuelas I, Ponchel G, Irache JM (2011) Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery. Expert Opin Drug Deliv 8:721–734. https://doi.org/10.1517/17425247.2011.572069
Ahmed GHG, Laíño RB, Calzón JAG, García MED (2014) Magnetic nanoparticles grafted with β-cyclodextrin for solid-phase extraction of 5-hydroxy-3-indole acetic acid. Microchim Acta 181:941–948. https://doi.org/10.1007/s00604-014-1192-y
Ammar H, El-Nahhas S, Ghorab M, Salama A (2012) Chitosan/Cyclodextrin nanoparticles as drug delivery system. J Incl Phenom Macrocycl Chem 72:9950–9955. https://doi.org/10.1007/s10847-011
Anirudhan TS, Dilu D, Sandeep S (2013) Synthesis and characterisation of chitosan crosslinked-β-cyclodextrin grafted silylated magnetic nanoparticles for controlled release of Indomethacin. J Magn Magn Mater 343:149–156. https://doi.org/10.1016/j.jmmm.2013.04.007
Aranda C, Urbiola K, Méndez Ardoy A, García Fernández JM, Ortiz Mellet C, de Ilarduya CT (2013) Targeted gene delivery by new folate-polycationic amphiphilic cyclodextrin-DNA nanocomplexes in vitro and in vivo. Eur J Pharm Biopharm 85:390–397. https://doi.org/10.1016/j.ejpb.2013.06.011
Arima H, Hagiwara Y, Hirayama F, Uekama K (2006) Enhancement of antitumor effect of doxorubicin by its complexation with γ-cyclodextrin in pegylated liposomes. J Drug Target 14:225–232. https://doi.org/10.1080/10611860600711136
Arora D, Saneja A, Jaglan S (2019) Cyclodextrin-based delivery systems for dietary pharmaceuticals. Environ Chem Lett 17:1263–1270. https://doi.org/10.1007/s10311-019-00878-w
Baek JS, Kim JH, Park JS, Cho CW (2015) Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection. Int J Nanomed 10:5397–5405. https://doi.org/10.2147/IJN.S86474
Bakar F, Caglayan M, Onur F, Nebioglu S, Palabiyik I (2015) Gold nanoparticle-lignan complexes inhibited MCF-7 cell proliferation in vitro: a novel conjugation for cancer therapy. anticancer agents. Med Chem 15:336–344. https://doi.org/10.2174/1871520614666141202144152
Banerjee SS, Chen DH (2007) Magnetic nanoparticles grafted with cyclodextrin for hydrophobi drug delivery. Chem Mater 19:6345–6349. https://doi.org/10.1021/cm702278u
Behera A, Padhi S (2020) Passive and active targeting strategies for the delivery of the camptothecin anticancer drug: a review. Environ Chem Lett 18:1557–1567. https://doi.org/10.1007/s10311-020-01022-9
Bilensoy E (2011) Cyclodextrins in pharmaceutics, cosmetics and biomedicine. Current and future industrial applications. Wiley, Hoboken. https://doi.org/10.1002/9780470926819
Bilensoy E, Hincal AA (2009) Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. Expert Opin Drug Deliv 6:1161–1173. https://doi.org/10.1517/17425240903222218
Bilensoy E, Gürkaynak O, Doǧan AL, Hincal AA (2008a) Safety and efficacy of amphiphilic ß-cyclodextrin nanoparticles for paclitaxel delivery. Int J Pharm 347:163–170. https://doi.org/10.1016/j.ijpharm.2007.06.051
Bilensoy E, Gürkaynak O, Ertan M, Şen M, Hincal AA (2008b) Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel. J Pharm Sci 97:1519–1529. https://doi.org/10.1002/jps.21111
Bu X, Zhu T, Ma Y, Shen Q (2015) Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles. Drug Dev Ind Pharm 41:764–771. https://doi.org/10.3109/03639045.2014.902465
Campos EVR, Proença PLF, Oliveira JL, Melville CC, Vechia JFD, De Andrade DJ, Fraceto LF (2018) Chitosan nanoparticles functionalized with β-cyclodextrin: a promising carrier for botanical pesticides. Sci Rep. https://doi.org/10.1038/s41598-018-20602-y
Carlotti M, Sapino S, Ugazio E, Gallarate M, Morel S (2012) Resveratrol in solid lipid nanoparticles. J Disper Sci Tech 33:465–471. https://doi.org/10.1080/01932691.2010.548274
Challa R, Ahuja A, Ali J, Khar RK (2005) Cyclodextrins in drug delivery: an updated review. AAPS Pharm SciTech 6:2. https://doi.org/10.1208/pt060243
Chaudhari VS, Murty US, Banerjee S (2020) Lipidic nanomaterials to deliver natural compounds against cancer: a review. Environ Chem Lett 18:1803–1812. https://doi.org/10.1007/s10311-020-01042-5
Chen P, Song H, Yao S, Tu X, Su M, Zhou L (2017) Magnetic targeted nanoparticles based on β-cyclodextrin and chitosan for hydrophobic drug delivery and a study of their mechanism. RSC Adv 7:29025–29034. https://doi.org/10.1039/C7RA02398G
Chen P, Yao S, Chen X, Huang Y, Song H (2019) A new strategy for the construction of β-cyclodextrin-based magnetic nanocarriers: a molecular docking technique. New J Chem 43:4282–4290. https://doi.org/10.1039/c8nj06131a
Çirpanli Y, Bilensoy E, Lale Doǧan A, Çaliş S (2009) Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Eur J Pharm Biopharm 73:82–89. https://doi.org/10.1016/j.ejpb.2009.04.013
Çirpanli Y, Allard E, Passirani C, Bilensoy E, Lemaire L, Caliş S, Benoit JP (2011) Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model. Int J Pharm 17:201–206. https://doi.org/10.1016/j.ijpharm.2010.10.015
Cirri M, Bragagni M, Mennini N, Mura P (2012) Development of a new delivery system consisting in “drug - In cyclodextrin - In nanostructured lipid carriers” for ketoprofen topical delivery. Eur J Pharm Biopharm 80:46–53. https://doi.org/10.1016/j.ejpb.2011.07.015
Cirri M, Mennini N, Maestrelli F, Mura P, Mannelli GCC, L, (2017) Development and in vivo evaluation of an innovative “hydrochlorothiazide-in cyclodextrins-in solid lipid nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics. Int J Pharm 521:73–83. https://doi.org/10.1016/j.ijpharm.2017.02.022
Cirri M, Maestrelli F, Mura P, Ghelardini C, Mannelli LDC (2018) Combined approach of cyclodextrin complexation and nanostructured lipid carriers for the development of a pediatric liquid oral dosage form of hydrochlorothiazide. Pharmaceutics 10:287. https://doi.org/10.3390/pharmaceutics10040287
Conte C, Costabile G, d’Angelo I, Pannico M, Musto P, Grassia G, Ialenti A, Tirino P, Miro A, Ungaro F, Quaglia F (2015) Skin transport of PEGylated poly(ε-caprolactone) nanoparticles assisted by (2-hydroxypropyl)-β-cyclodextrin. J Colloid Interface Sci 454:112–120. https://doi.org/10.1016/j.jcis.2015.05.010
Crini G, Fourmentin S, Fenyvesi É, Torri G, Fourmentin M, Morin-Crini N (2018) Cyclodextrins, from molecules to applications. Environ Chem Lett 16:1361–1375. https://doi.org/10.1007/s10311-018-0763-2
Crini G, Fenyvesi É, Szente L (2021) Outstanding contribution of Professor József Szejtli to cyclodextrin applications in foods, cosmetics, drugs, chromatography and biotechnology: a review. Environ Chem Lett 19:2619–2641. https://doi.org/10.1007/s10311-020-01170-y
Da Silveira AM, Ponchel G, Puisieux F, Duchêne D (1998) Combined poly (isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm Res 15:1051–1055. https://doi.org/10.1023/A:1011982211632
Datz S, Illes B, Gößl D, Schirnding CV, Engelke H, Bein T (2018) Biocompatible crosslinked β-cyclodextrin nanoparticles as multifunctional carriers for cellular delivery. Nanoscale 10:16284–16292. https://doi.org/10.1039/c8nr02462f
Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, He J, Alb A, John V, Pochampally R (2012) Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine 8:440–451. https://doi.org/10.1016/j.nano.2011.07.011
Díaz-Moscoso A, Guilloteau N, Bienvenu C, Méndez-Ardoy A, Jiménez Blanco J, Benito J, Gourriérec L, Di Giorgio C, Vierling P, Defaye J, Mellet C, García Fernández J (2011) Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery. Biomaterials 32:7263–7273. https://doi.org/10.1016/j.biomaterials.2011.06.025
Ding Y, Shen SZ, Sun H, Sun K, Liu F, Qi Y, Yan J (2015) Design and construction of polymerized-chitosan coated Fe3O4 magnetic nanoparticles and its application for hydrophobic drug delivery. Mater Sci Eng C 48:487–498. https://doi.org/10.1016/j.msec.2014.12.036
Donohue R, Mazzaglia A, Ravoo BJ, Darcy R (2002) Cationic β-cyclodextrin bilayer vesicles. Chem Commun 2:2864–2865. https://doi.org/10.1039/b207238f
Enoch IVMV, Ramasamy S, Gopinath MSP (2018) Cyclodextrin-PEG conjugate-wrapped magnetic ferrite nanoparticles for enhanced drug loading and release. Appl Nanosci 8:273–284. https://doi.org/10.1007/s13204-018-0798-5
Erdogar N, Varan G, Bilensoy E (2017) Amphiphilic cyclodextrin derivatives for targeted drug delivery to tumors. Curr Top Med Chem 17:1521–1528. https://doi.org/10.2174/1568026616666161222101104
Evans J, Malhotra M, Fitzgerald K, Guo J, Cronin M, Curtin C, O’Brien F, Darcy R, O’ Driscoll K (2017) Formulation and evaluation of anisamide-targeted amphiphilic cyclodextrin nanoparticles to promote therapeutic gene silencing in a 3d prostate cancer bone metastases model. Mol Pharm 3:42–52. https://doi.org/10.1021/acs.molpharmaceut.6b00646
Gannimani R, Ramesh M, Mtambo S, Pillay K, Soliman ME, Govender P (2016) γ-Cyclodextrin capped silver nanoparticles for molecular recognition and enhancement of antibacterial activity of chloramphenicol. J Inorg Biochem 157:15–24. https://doi.org/10.1016/j.jinorgbio.2016.01.008
García-González L, Yépez-Mulía L, Ganem A (2016) Effect of β-cyclodextrin on the internalization of nanoparticles into intestine epithelial cells. Eur J Pharm Sci 81:113–118. https://doi.org/10.1016/j.ejps.2015.10.012
Gaurav C, Nikhil G, Deepti S, Kalra S, Goutam R, Amit GK (2015) Albumin stabilized silver nanoparticles-clotrimazole β-cyclodextrin hybrid nanocomposite for enriched anti-fungal activity in normal and drug resistant Candida cells. RSC Adv 5:71190–71202. https://doi.org/10.1039/c5ra08274a
Gèze A, Chau LT, Choisnard L, Mathieu JP, Marti-Batlle D, Riou L, Putaux JL, Wouessidjewe D (2007) Biodistribution of intravenously administered amphiphilic β-cyclodextrin nanospheres. Int J Pharm 344:135–142. https://doi.org/10.1016/j.ijpharm.2007.06.050
Ghera BB, Perret F, Chevalier Y, Parrot-Lopez H (2009) Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir. Int J Pharm 22:155–162. https://doi.org/10.1016/j.ijpharm.2009.04.004
Godinho BMDC, Ogier JR, Darcy R, O’Driscoll CM, Cryan JF (2013) Self-assembling modified β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on huntington’s disease. Mol Pharm 10:640–649. https://doi.org/10.1021/mp3003946
Godinho BMDC, Ogier JR, Quinlan A, Darcy R, Griffin BT, Cryan JF, Caitriona MOD (2014) PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability. Int J Pharm 473:105–112. https://doi.org/10.1016/j.ijpharm.2014.06.054
Gooding M, Malhotra M, McCarthy DJ, Godinho BMDC, Cryan JF, Darcy R, O’Driscoll CM (2015) Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: In vitro analysis. Eur J Pharm Sci 71:80–92. https://doi.org/10.1016/j.ejps.2015.02.007
Gorjikhah F, Azizi Jalalian F, Salehi R, Panahi Y, Hasanzadeh A, Alizadeh E, Akbarzadeh A, Davaran S (2017) Preparation and characterization of PLGA-β-cyclodextrin polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line. Artif Cells Nanomed Biotechnol 45:432–440. https://doi.org/10.3109/21691401.2016.1160915
Guo J, Ogier JR, Desgranges S, DarcyODriscoll RC (2012) Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice. Biomaterials 33:7775–7784. https://doi.org/10.1016/j.biomaterials.2012.07.012]
Guo B, Xu D, Liu X, Liao C, Li S, Huang Z, Li X, Yi J (2017) Characterization and cytotoxicity of PLGA nanoparticles loaded with formononetin cyclodextrin complex. J Drug Deliv Sci Technol 41:375–383. https://doi.org/10.1016/j.jddst.2017.08.010
Hamada H, Ishihara K, Masuoka N, Mikuni K, Nakajima N (2006) Enhancement of water-solubility and bioactivity of paclitaxel using modified cyclodextrins. J Biosci Bioeng 102:369–371. https://doi.org/10.1263/jbb.102.369
He M, Zhong C, Hu H, Jin Y, Chen Y, Lou K, Gao F (2019) Cyclodextrin/chitosan nanoparticles for oral ovalbumin delivery: preparation, characterization and intestinal mucosal immunity in mice. Asian J Pharm Sci 14:193–203. https://doi.org/10.1016/j.ajps.2018.04.001
Hippalgaonkar K, Adelli GR, Hippalgaonkar K, Repka MA, Majumdar S (2013) Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J Ocul Pharmacol Ther 29:216–228. https://doi.org/10.1089/jop.2012.006
Hou X, Zhang W, He M, Lu Y, Lou K, Gao F (2017) Preparation and characterization of β-cyclodextrin grafted N-maleoyl chitosan nanoparticles for drug delivery. Asian J Pharm Sci 12:558–568. https://doi.org/10.1016/j.ajps.2017.07.007
Ji T, Li S, Zhang Y, Lang J, Ding Y, Zhao X, Zhao R, Li Y, Shi J, Hao J, Zhao Y, Nie G (2016) An MMP-2 responsive liposome integrating antifibrosis and chemotherapeutic cyclodextrin drugs for enhanced drug perfusion and efficacy in pancreatic cancer. ACS Appl Mater Interfaces 8:3438–3445. https://doi.org/10.1021/acsami.5b11619
Kadari A, Gudem S, Kulhari H, Bhandi MM, Borkar RM, Kolapalli VRM, Sistla R (2017) Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles. Drug Deliv 24:224–232. https://doi.org/10.1080/10717544.2016.1245366
Khalil SK, El-Feky GS, El-Banna ST, Khalil WA (2012) Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Carbohydr Polym 15:1244–1253. https://doi.org/10.1016/j.carbpol.2012.06.056
Langie SAS, Knaapen AM, Houben JMJ, van Kempen FC, de Hoon JPJ, Gottschalk RWH, Godschalk RWL, van Schooten FJ (2007) The role of glutathione in the regulation of nucleotide excision repair during oxidative stress. Toxicol Lett 168:302–309. https://doi.org/10.1016/j.toxlet.2006.10.027
Lin C, Chen F, Ye T, Zhang L, Zhang W, Liu D, Xiong W, Yang X, Pan W (2014) A novel oral delivery system consisting in “drug-in cyclodextrin-in nanostructured lipid carriers” for poorly water-soluble drug: Vinpocetine. Int J Pharm 465:90–96. https://doi.org/10.1016/j.ijpharm.2014.02.013
Liu J, Xu R, Kaifer AE (1998) In situ modification of the surface of gold colloidal particles. Preparation of cyclodextrin-based rotaxanes supported on gold nanospheres. Langmuir 14:7337–7339. https://doi.org/10.1021/la981385q
Luppi B, Bigucci F, Corace G, Delucca A, Cerchiara T, Sorrenti M, Catenacci L, Di Pietra AM, Zecchi V (2011) Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-alzheimer drug tacrine. Eur J Pharm Sci 44:559–65. https://doi.org/10.1016/j.ejps.2011.10.002
Lysik MA, Wu-Pong S (2003) Innovations in oligonucleotide drug delivery. J Pharm Sci 92:1559–1573. https://doi.org/10.1002/jps.10399
Mady FM, Abou-Taleb AE, Khaled KA, Yamasaki K, Iohara D, Taguchi K, Anraku M, Hirayama F, Uekama K, Otagiri M (2010) Evaluation of carboxymethyl-β-cyclodextrin with acid function: Improvement of chemical stability, oral bioavailability and bitter taste of famotidine. Int J Pharm 397:1–8. https://doi.org/10.1016/j.ijpharm.2010.06.018
Maestrelli F, Garcia-Fuentes M, Mura P, Alonso MJ (2006) A new drug nanocarrier consisting of chitosan and hydroxyl propyl cyclodextrin. Eur J Pharm Biopharm 63:79–86. https://doi.org/10.1016/j.ejpb.2005.12.006
Mahmoud AA, El-Feky GS, Kamel R, Awad GEA (2011) Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm 413:229–236. https://doi.org/10.1016/j.ijpharm.2011.04.031
McCormack B, Gregoriadis G (1994) Drugs-in-cyclodextrins-in liposomes: a novel concept in drug delivery. Int J Pharm 112:249–258. https://doi.org/10.1016/0378-5173(94)90361-1
Méndez-Ardoy A, Guilloteau N, Di Giorgio C, Vierling P, Santoyo-González F, Ortiz Mellet C, García Fernández JM (2011) β-cyclodextrin-based polycationic amphiphilic “click” clusters: effect of structural modifications in their DNA complexing and delivery properties. J Org Chem 76:5882–5894. https://doi.org/10.1021/jo2007785
Mennini N, Cirri M, Maestrelli F, Mura P (2016) Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: effect of cyclodextrin complexation. Int J Pharm 515:684–691. https://doi.org/10.1016/j.ijpharm.2016.11.013
Merkus FWHM, Verhoef JC, Marttin E, Romeijn SG, Van Der Kuy PHM, Hermens WAJJ, Schipper NGM (1999) Cyclodextrins in nasal drug delivery. Adv Drug Deliv Rev 36:41–57. https://doi.org/10.1016/S0169-409X(98)00054-4
Messner M, Kurkov SV, Jansook P, Loftsson T (2010) Self-assembled cyclodextrin aggregates and nanoparticles. Int J Pharm 387:199–208. https://doi.org/10.1016/j.ijpharm.2009.11.035
Morin-Crini N, Fourmentin S, Fenyvesi É, Lichtfouse E, Torri G, Fourmentin M, Crini G (2021) 130 years of cyclodextrin discovery for health, food, agriculture, and the industry: a review. Environ Chem Lett. https://doi.org/10.1007/s10311-020-01156-w
Nguyen HT, Goycoolea FM (2017) Chitosan/Cyclodextrin/TPP nanoparticles loaded with quercetin as novel bacterial quorum sensing inhibitors. Molecules 22:1975. https://doi.org/10.3390/molecules22111975
Pandey A (2020) Role of Cyclodextrins in Nanoparticle-Based Systems for Drug Delivery. In: Crini G, Fourmentin S, Lichtfouse E (eds) The history of cyclodextrins, vol 52. Springer, Cham, pp 305–343
Pandey A (2021) Pharmaceutical and biomedical applications of cellulose nanofibers: a review. Environ Chem Lett 19:2043–2055. https://doi.org/10.1007/s10311-021-01182-2
Petitjean M, García-Zubiri IX, Isasi JR (2021) History of cyclodextrin-based polymers in food and pharmacy: a review. Environ Chem Lett. https://doi.org/10.1007/s10311-021-01244-5
Pires FQ, da Silva JKR, Sa-Barreto LL, Gratieri T, Gelfuso GM, Cunha-Filho M (2019) Lipid nanoparticles as carriers of cyclodextrin inclusion complexes: a promising approach for cutaneous delivery of a volatile essential oil. Colloids Surf B Biointerfaces 182:110382. https://doi.org/10.1016/j.colsurfb.2019.110382
Prabha G, Raj V (2016) Formation and characterization of β-cyclodextrin (β-cyclodextrin)–polyethyleneglycol (PEG)-polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-fluorouracil drug. Biomed Pharmacother 80:173–182. https://doi.org/10.1016/j.biopha.2016.03.015
Prandina A, Herfindal L, Radix S, Rongved P, Døskeland SO, Le Borgne M, Perret F (2018) Enhancement of iodinin solubility by encapsulation into cyclodextrin nanoparticles. J Enzyme Inhib Med Chem 33:370–375. https://doi.org/10.1080/14756366.2017.1421638
Quaglia F, Ostacolo L, Mazzaglia A, Villari V, Zaccaria D, Sciortino MT (2009) The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs. Biomaterials 30:374–382. https://doi.org/10.1016/j.biomaterials.2008.09.035
Ren S, Chen D, Jiang M (2009) Noncovalently connected micelles based on a β-cyclodextrin-containing polymer and adamantane end-capped poly(ε-caprolactone) via host-guest interactions. J Polym Sci Part A Polym Chem 47:4267–4278. https://doi.org/10.1002/pola.23479
Skiba M, Wouessidjewe D, Coleman A, Fessi H, Devissaguet JP, Duchene D, Puisieux F (1993) Preparation and use of novel cyclodextrin-based dispersible colloidal systems in the form of nanospheres. PCT Int Appl 23 pp. PCT Applications FR 93/00594 (Publication No. WO 93/25195)
Spada G, Gavini E, Cossu M, Rassu G, Giunchedi P (2012) Solid lipid nanoparticles with and without hydroxypropyl β-cyclodextrin: a comparative study of nanoparticles designed for colonicyclodextrinrug delivery. Nanotechnology. https://doi.org/10.1088/0957-4484/23/9/095101
Szente L, Szejtli J (1999) Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv Drug Deliv Rev. https://doi.org/10.1016/S0169-409X(98)00092-1
Tao HQ, Meng Q, Li MH, Yu H, Liu MF, Du D, Sun SL, Yang HC, Wang YM, Ye W, Yang LZ, Zhu DL, Jiang CL, Peng HS (2013) HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats. Naunyn Schmiedebergs Arch Pharmacol 386:61–70. https://doi.org/10.1007/s00210-012-0804-5
Teijeiro-Osorio D, Remuñán-López C, Alonso MJ (2009) Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. Eur J Pharm Biopharm 71:257–263. https://doi.org/10.1016/J.EJPB.2008.09.020
Trapani A, Lopedota A, Franco M, Cioffi N, Ieva E, Garcia-Fuentes M, Alonso MJ (2010) A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. Eur J Pharm Biopharm 75:26–32. https://doi.org/10.1016/j.ejpb.2010.01.010
Vaidya B, Parvathaneni V, Kulkarni NS, Shukla SK, Damon JK, Sarode A, Kanabar D, Garcia JV, Mitragotri S, Muth A, Gupta V (2019) Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer. Int J Biol Macromol 122:338–347. https://doi.org/10.1016/j.ijbiomac.2018.10.181
Vakhariya RR, Talokar SS, Salunkhe VR, Magdum CS (2017) Formulation development and optimization of simvastatin loaded solid lipid nanoparticles. Asian J Res Pharm Sci 7:49. https://doi.org/10.5958/2231-5659.2017.00008.x
Varan G, Öncül S, Ercan A, Benito JM, Ortiz Mellet C, Bilensoy E (2016) Cholesterol-targeted anticancer and apoptotic effects of anionic and polycationic amphiphilic cyclodextrin nanoparticles. J Pharm Sci 105:3172–3182. https://doi.org/10.1016/j.xphs.2016.06.021
Varan G, Patrulea V, Borchard G, Bilensoy E (2018) Cellular interaction and tumoral penetration properties of cyclodextrin nanoparticles on 3D breast tumor model. Nanomaterials 8:1–18. https://doi.org/10.3390/nano8020067
Wang Y, Wong JF, Teng X, Lin XZ, Yang H (2003) “Pulling” nanoparticles into water: phase transfer of oleic acid stabilized monodisperse nanoparticles into aqueous solutions of α-cyclodextrin. Nano Lett 3:1555–1559. https://doi.org/10.1021/nl034731j
Wang T, Zhang C, Liang XJ, Liang W, Wu Y (2011) Hydroxypropyl-β-cyclodextrin copolymers and their nanoparticles as doxorubicin delivery system. J Pharm Sci 100:1067–1079. https://doi.org/10.1002/jps.22352
Wang D, Wang T, Xu Z, Yu H, Feng B, Zhang J, Guo C, Yin Q, Zhang Z, Li Y (2016a) Cooperative treatment of metastatic breast cancer using host-guest nanoplatform coloaded with docetaxel and siRNA. Small 12:488–498. https://doi.org/10.1002/smll.201502913
Wang Y, Li H, Jin Q, Ji J (2016b) Intracellular host-guest assembly of gold nanoparticles triggered by glutathione. Chem Commun 52:582–585. https://doi.org/10.1039/c5cc07195j
Wang X, Gao Z, Zhang L, Wang H, Hu X (2018) A magnetic and pH-sensitive composite nanoparticle for drug delivery. J Nanomater. https://doi.org/10.1155/2018/1506342
Weiss G, Yen Y, Neidhart J, Young CS, Weiss S, Ryan J (2011) Abstract 1306: A Phase 1b/2a study of CRLX101, a novel nanopharmaceutical of camptothecin, in solid tumor cancer patients who have failed standard therapy. In: Clinical Research. American Association for Cancer Research, pp 1306–1306. https://doi.org/10.1158/1538-7445.AM2011-1306
Xu Z, Liu S, Liu H, Yang C, Kang Y, Wang M (2015) Unimolecular micelles of amphiphilic cyclodextrin-core star-like block copolymers for anticancer drug delivery. Chem Commun 51:15768–15777. https://doi.org/10.1039/c5cc02743h
Ye Z, Zhang Q, Wang S, Bharate P, Varela-Aramburu S, Lu M, Seeberger PH, Yin J (2016) Tumor-targeted drug delivery with mannose-functionalized nanoparticles self-assembled from amphiphilic β-cyclodextrins. Chem Eur J 22:15216–15221. https://doi.org/10.1002/chem.201603294
Zhai Z, Zhang F, Chen X, Zhong J, Liu G, Tian Y, Huang Q (2017) Uptake of silver nanoparticles by DHA-treated cancer cells examined by surface-enhanced Raman spectroscopy in a microfluidic chip. Lab Chip 17:1306–1313. https://doi.org/10.1039/c7lc00053g
Zhang N, Li JJ, Jiang W, Ren C, Li JJ, Xin J, Li K (2010) Effective protection and controlled release of insulin by cationic β-cyclodextrin polymers from alginate/chitosan nanoparticles. Int J Pharm 393:213–219. https://doi.org/10.1016/j.ijpharm.2010.04.006
Zhang X, Zheng X, Wu Z, Gao X, Shu S, Wang Z, Li C (2011) β-Cyclodextrin grafting hyperbranched polyglycerols as carriers for nasal insulin delivery. Carbohydr Polym 84:1419–1425. https://doi.org/10.1016/j.carbpol.2011.01.057
Zokaei E, Badoei-dalfrad A, Ansari M (2019) Therapeutic potential of DNAzyme loaded on chitosan/cyclodextrin nanoparticle to recovery of chemosensitivity in the MCF-7 cell line. Appl Biochem Biotechnol 187:708. https://doi.org/10.1007/s12010-018-2836-x
Zuckerman JE, Gritli I, Tolcher A, Heidel JD, Lim D, Morgan R, Chmielowski B, Ribas A, Davis ME, Yen Y (2014) Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci USA 111:11449–11454. https://doi.org/10.1073/pnas.1411393111
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Consent for publication
I hereby give my consent for the publication of manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pandey, A. Cyclodextrin-based nanoparticles for pharmaceutical applications: a review. Environ Chem Lett 19, 4297–4310 (2021). https://doi.org/10.1007/s10311-021-01275-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10311-021-01275-y